disease in humans. However, infection with the 1918 H1N1 pandemic or highly 28 pathogenic avian influenza viruses (HPAIV) of the H5N1 subtype, can lead to viral 29 pneumonia, systemic disease and death. The molecular processes that determine 30 the outcome of influenza virus infection are multifactorial and involve a complex 31 interplay between host, viral, and bacterial factors 1 . However, it is generally 32 accepted that a strong innate immune dysregulation known as 'cytokine storm' 33 contributes to the pathology of pandemic and avian influenza virus infections [2][3][4] . 34 The RNA sensor Retinoic acid-inducible gene I (RIG-I) plays an important role in 35 sensing viral infection and initiating a signalling cascade that leads to interferon 36 (IFN) expression 5 . Here we show that short aberrant RNAs (mini viral RNAs; 37 mvRNAs), produced by the viral RNA polymerase during the replication of the 38 viral RNA genome, bind and activate the intracellular pathogen sensor RIG-I, and 39 lead to the expression of interferon-b. We find that erroneous polymerase activity, 40 dysregulation of viral RNA replication, or the presence of avian-specific amino 41 acids underlie mvRNA generation and cytokine expression in mammalian cells 42
responsible for triggering IFN expression, we expressed a full-length segment 4 79 (hemagglutinin encoding) vRNA (1775 nt long) or its truncated versions, a 245 nt long 80 DI RNA and 77 nt long mvRNA, in HEK 293T cells together with viral polymerase, 81 NP and a luciferase reporter to measure the activation of the IFN-b promoter ( Fig. 1b) . 82
We found that the expression of mvRNAs induced significantly higher IFN expression 83 than full-length vRNA or DI RNA, comparable to the levels induced by transfection of 84 2 µg of poly(I:C), a known activator of IFN expression 18 . Similar results were obtained 85 with segment 5 and 6 (NP and neuraminidase encoding, respectively) vRNAs and their 86 truncated DI RNA and mvRNA versions ( Fig. 1b) . To determine the optimal mvRNA 87 length that triggers activation of the IFN-b promoter, we expressed 47 to 246 nt long 88 vRNAs derived from segment 5 together with viral polymerase and NP and measured 89 the activity of the IFN-b promoter. We found that the replication of 56 to 125 nt long 90 mvRNAs resulted in significantly higher IFN-b promoter activity than the replication 91 of RNAs shorter than 56 nt or longer than 125 nt (Fig. 1c, Fig. S1a and b) . 92
To address whether these engineered short mvRNAs triggered IFN expression 93 via RIG-I, we co-expressed viral RNAs with polymerase and NP in HEK 293T RIG-I 94 knockout (RIG-I -/-) or control (RIG-I +/+) cells engineered to express luciferase in 95 response to the activation of the IFN-b promoter. We found that 56 to 125-nt long 96 mvRNAs induced only background levels of luciferase in RIG-I -/-cells, even though 97 the transfection of a plasmid expressing RIG-I or 2 µg of poly(I:C) resulted in 98 significant activation of the IFN-b promoter (Fig. 1d, Fig. S1c ). By contrast, significant 99 levels of luciferase activity were detected in RIG-I +/+ cells (Fig. 1d ). mvRNAs of 56 100 to 125 nt induced the strongest activation of the IFN-b promoter, in agreement with the 101 data above ( Fig. 1c and d, Fig. S1c and d) . To address whether mvRNAs trigger the 102 activation of IFN-b expression through binding to RIG-I, we immunoprecipitated myc-103 RIG-I from cells expressing RNAs of 47 to 583 nt and analysed the amounts of co-104 immunoprecipiated RNAs. We observed that mvRNAs of 56 to 125 nt were specifically 105 enriched in RIG-I immunoprecipitates (Fig. 1e, Fig. S1e ). No mvRNAs were detected 106 in mouse myc-EGF immunoprecipitates used as a negative control (Fig. 1e ). To test if 107 mvRNAs also activate RIG-I, we incubated purified myc-RIG-I ( Fig. S1f) with an in 108 vitro transcribed and gel purified 76 nt mvRNA and measured 32 Pi release in an ATPase 109 assay. We found that a triphosphorylated 76 nt mvRNA induced higher levels of 110 ATPase activity than a dephosphorylated 76 nt mvRNA, while no ATPase activity was 111 observed when we incubated a RIG-I mutant with the triphosphorylated 76 nt mvRNA 112 ( Fig. S1g ). Overall, these results demonstrate that mvRNAs longer than 47 and shorter 113 than 125 nt are bound by RIG-I, which results in RIG-I activation and the induction of 114 IFN-b expression. This is in agreement with findings that reconstitution of full-length 115 influenza virus vRNPs leads to only low levels of IFN expression unless the cells are 116 pre-treated with IFN 19 and the hypothesis that aberrant replication products trigger the 117 IFN induction cascade 12 . 118 We next asked whether mvRNAs are made during influenza virus infection. We 119 infected HEK 293T cells with influenza A/WSN/33 (H1N1) (abbreviated as WSN) and 120 analysed viral RNAs by RT-PCR of segment 1 (encoding PB2), RT-PCR of all 121 segments using universal primers ( Fig. S2a ), or deep-sequencing of the total small RNA 122 fraction (RNAs 17 to 200 nt in length) ( Fig. S2b) . We found only very low levels of 123 mvRNAs and, consistently, observed no significant IFN expression ( Fig. 2a and b ). We 124 hypothesised that mvRNAs are only generated as a consequence of dysregulated viral 125 RNA replication. To test this, we overexpressed viral RNA polymerase from plasmids 126 prior to infection to generate an imbalance between polymerase and NP levels, which 127 is known to induce innate immune signalling 20 . As shown in Fig. 2a and b, under this 128 condition we found significantly higher levels of mvRNAs and IFN expression, while 129 simultaneous overexpression of NP and polymerase reduced mvRNA and IFN 130 production ( Fig. 2a ). We verified the identity of mvRNAs using gel isolation and 131 Sanger sequencing ( Fig. S2c ) as well as deep sequencing (Fig. 2b ). We found that the 132 majority of mvRNAs were derived from the PB1-, HA-, NP-and NA-encoding vRNA 133 segments ( Fig. 2c ) and that mvRNAs had a size distribution with a peak around 55 to 134 64 nt ( Fig. 2d, Fig. S2d ). In addition to mvRNAs, we also identified complementary 135 mini viral RNAs (mcRNAs). 136
Analysis of mvRNA sequences suggests that mvRNAs are generated via an 137 intramolecular copy-choice mechanism that tolerates 3' mismatches or skipped bases 138 ( Fig. 2e and f). As shown in Fig. 2g , the generation of mvRNAs can be explained by 139 the separation of the template and nascent product RNAs by backtracking 21 , followed 140 by template translocation until base pairing between template and nascent product RNA 141 is re-established ( Fig. 2f and g) . This process may be induced by an imbalance between 142 viral polymerase and NP levels ( Fig. 2a, Fig. S3a ). In light of these results, it is 143 important to note that the existence of mvRNAs has likely been overlooked till now, 144 because i) RNA isolation protocols vary in their capacity to recover small RNAs, ii) 145 RT-PCR products from mvRNAs form a diffuse fast-migrating band on standard 146 agarose gels that may be mistaken for primer-dimers, iii) conventional RNA deep 147 sequencing protocols discard short library fragments, and iv) standard ligation-based 148 deep sequencing protocols for small RNAs require a 5ʹ monophosphate and do not 149 detect viral transcripts with a 5ʹ-triphosphate group. 150
In humans, infection with the 1918 H1N1 pandemic virus or H5N1 HPAIV lead 151 to strong innate immune activation 2,3,16 . To address whether mvRNAs could contribute 152 to this phenomenon, we investigated the replication of a 246 nt RNA by the polymerase 153 of these viruses. We found that the polymerases of the highly virulent A/Brevig 154 Mission/1/18 (H1N1) (abbreviated as BM18) pandemic virus and the 155 A/duck/Fujian/01/02 (H5N1) (abbreviated as FJ02) HPAIV generated higher levels of 156 mvRNAs than the polymerases of WSN and A/Northern Territory/60/68 (H3N2) 157 (abbreviated as NT60) viruses, even in the presence of high NP concentrations (Fig. 158 3a) . No mvRNAs were observed in a control with an inactive WSN polymerase that 6 had two point mutations in the polymerase active site (PB1a). Using gel isolation and 160
Sanger sequencing we confirmed that the mvRNAs produced by the BM18 polymerase 161 were similar to the WSN mvRNAs ( Fig. S3b ). Isolation of total RNA from cells 162 expressing polymerase of the BM18 or FJ02 virus and its subsequent transfection into 163 HEK 293T cells resulted in significantly higher IFN-b promoter activity compared to 164 when RNA from cells expressing WSN, NT60, or active site mutant WSN PB1a 165 polymerase was transfected ( Fig. 3a) . 166
The identification of mismatches and base-skipping during the generation of 167 mvRNAs (see Fig. 2e ) suggests that mvRNA production might be dependent on 168 polymerase fidelity. To investigate this further, we introduced a V43I mutation, which 169 has been shown to confer high-fidelity on an H5N1 influenza virus polymerase 22 , into 170 the PB1 subunit of the BM18 polymerase (BM18 hf ). We found that mvRNA levels were 171 significantly reduced in the presence of BM18 hf , with a corresponding reduction in IFN-172 b promoter activity ( Fig. 3a) . Together, the observations in Fig suggest that dysregulation of viral RNA replication, e.g. by limiting NP availability, 174 and replication by highly pathogenic avian influenza virus polymerases in mammalian 175 cells generates mvRNAs by employing an error-prone copy-choice mechanism, such 176 as proposed for recombination in positive-strand RNA viruses 23 . 177
Having observed a significant difference in mvRNA production by the WSN 178 and BM18 polymerases, we next asked whether a particular subunit is the determinant 179 of mvRNA production. Therefore, we replaced individual polymerase subunits of the 180 BM18 polymerase with subunits of the WSN polymerase in the 246 nt RNA replication 181 assay. We found that particularly replacement of the BM18 PB2 subunit with the WSN 182 PB2 subunit eliminated the generation of mvRNAs ( Fig. S4a ). Interestingly, the BM18 183 influenza PB2 subunit has been linked to the enhancement of both the kinetics and the 184 magnitude of the host response to viral infection, leading to the induction of strong 185 inflammatory responses with increased cellular infiltration in the lungs of infected 186 mice 24 . To identify PB2 amino acid residues involved in the formation of mvRNAs, we 187 aligned the BM18, WSN, NT60 and FJ02 PB2 sequences and found four amino acid 188 positions that distinguish the BM18 and FJ02 polymerases from the WSN and NT60 189 polymerases: 9 (D®N), 64 (M®T), 81 (T®M), and 661 (A®T) ( Fig. S4a ). Each of 190 these amino acids has been implicated in avian to mammalian host adaptation 25 and, 191 interestingly, all three N-terminal PB2 adaptive amino acids map to the template exit 192 channel of the RNA polymerase heterotrimer (Fig. 3b ) 6 . We generated single mutations 193 N9D, T64M, M81T, and double mutations N9D+T64M and N9D+M81T in the PB2 194 subunit of the WSN polymerase and found that mutants N9D and M81T, and the double 195 mutants N9D+T64M and N9D+M81T, significantly increased mvRNA formation (Fig. 196 3c) and IFN-b promoter activity ( Fig. 3c and d) . However, the levels of mvRNAs 197 generated by these mutants did not reach the levels generated by the BM18 polymerase 198 indicating that further amino acids are involved in determining the ability of a 199 polymerase to produce mvRNAs. In line with our observations, WSN viruses that 200 contain a PB2 N9D substitution or other PB2 mutations near the template exit channel 201 have been reported to induce higher IFN-b expression than wild-type WSN 26, 27 . 202
To address whether mvRNAs form during infection of mammalian cells, we 203 infected A549 cells with WSN, the highly pathogenic avian strain A/Vietnam/1203/04 204 (H5N1) (abbreviated as VN04), and the VN04 virus with the PB1 V43I high-fidelity 205 mutation (abbreviated as VN04 hf ). PAGE and deep sequencing analysis using RT-PCR 206 universal primers ( Fig. S2a ) showed that infections with VN04 resulted in high levels 207 of mvRNAs, while WSN infections produced only very low levels ( Fig. 4a ). Infections 208 with VN04 hf resulted in significantly reduced mvRNA levels compared to the wild-type 209 VN04 virus. These results demonstrate that mvRNAs are formed during influenza virus 210 infection of lung epithelial cells and that polymerase fidelity is an important 211 determinant of mvRNA formation ( Fig. 4a ). 212
To investigate whether there is a link between mvRNA production and virus-213 induced innate immune responses we performed RNAseq of cells infected with VN04 214 and VN04 hf viruses, which differ only at a single amino acid residue, and examined 215 which genes were differentially expressed in response to mvRNA levels. Despite 216 significantly different mvRNA levels produced by VN04 and VN04 hf , viral mRNA 217 levels were similar (Data S1), in agreement with previous findings that the V43I 218 mutation has only a marginal effect on virus replication 22 . Gene Ontology (GO) 219 analysis ( Fig. 4b ) showed that basic cellular functions (e.g. translation and 220 transcription) were significantly compromised in VN04 infection relative to VN04 hf , 221 consistent with a greater level of cell death, which is known to exacerbate 222 inflammation 28 . In addition, we observed that genes associated with innate immune 223 responses showed a significant increase in expression in response to higher mvRNA 224 levels (Data S1, Fig. 4b ). Overall, these observations are indicative of a link between 225 erroneous polymerase activity, mvRNA synthesis, and innate immune activation and 226 the induction of cell death. Furthermore, as VN04 exhibited a 10-fold higher lethality 227 compared to V04 hf in mice 22 , our data also suggest a link between mvRNA levels and 228 virulence. 229
To address whether mvRNAs are also produced in infection of animal models, 230
we investigated mvRNA generation in ferrets, which are regarded as the gold-standard 231 model for influenza virus infection studies. Specifically, we analysed RNA samples 232 from ferret lungs one and three days after infection with highly pathogenic avian 233 These features of mvRNAs are likely to be critical for their preferential recognition by 249 RIG-I over DI RNAs and full length RNA segments. We further demonstrate that 250 mvRNA production is linked to increased cytokine expression and cell death. Since 251 high levels of mvRNAs lead to more innate immune activation and cell death, our 252 observations strongly suggest that mvRNAs are a contributing factor to influenza virus 253 virulence. We speculate that production of high levels of mvRNAs by the polymerases 254 of the 1918 pandemic and highly pathogenic avian influenza viruses and the resulting 255 increased innate immune activation contribute to the cytokine storm phenomenon 256 underlying the high virulence of these viral strains. The effects of mvRNAs are likely 257 modulated by viral factors, such as the immunomodulatory NS1 and PB1-F2 proteins 12 258 ( Fig. 4e ). Further studies are required to assess mvRNA levels generated by various 259 influenza virus strains, including seasonal strains, and their effect on virulence. 260 261 262
Methods

263
Ethics and biosafety 264
All work with highly pathogenic H5N1 viruses in A549 cells was conducted in the 265 previously 36, 37 . To construct plasmids expressing mutant PB1, PB2 proteins and myc-297 RIG-I (myc-RIG-I mut; which contains the mutations K851A, K858A and K861A), the 298 plasmids expressing wild-type proteins were subjected to site-directed mutagenesis 299 using the primers listed in Table S1 . Table S3 ). cDNA synthesis was stopped with 10 µl loading dye (90% formamide, 350 10 mM EDTA, xylene cyanole, bromophenol blue) and 32 P-labelled cDNAs generated 351 with primer NP-were resolved by 12% denaturing PAGE (19:1 acrylamide/bis-352 acrylamide, 1x TBE buffer, 7 M urea). 32 P-labelled cDNAs generated with primer NP- For segment-specific qualitative RNA analysis by RT-PCR, RNA was treated with 362 DNase (Promega) for 10 min according to the manufacturer's instructions and reverse 363 transcribed using SuperScript III and the PB2 primers listed in Table S3 . cDNA was 364 amplified using Q5 polymerase (NEB) and the primers listed in Table S3 . PCR products 365 were analysed on 1.5% agarose gels in 0.5x Tris-acetate-EDTA (TAE) buffer. For 366 qualitative RT-PCR using universal primers, DNase treated RNA was reverse 367 transcribed using the Lv3aa and Lv3ga primers listed in Table S3 and Superscript III at 368 37 ºC for 30 min. Second strands synthesis was performed with primer Lv5 and Q5 369 polymerase (NEB) at 47 ºC for 10 min, followed by a further extension at 72 ºC for 3 370 min. The primer excess in the reactions was removed by incubating the second strand 371 reaction with 1 U of exonuclease VII (NEB) at 37 degrees Celsius for 1 h. Following 372 inactivation of the exonuclease at 95 ºC for 10 min, the DNA was amplified using Q5 373 polymerase, and primers P5 and i7 for 25 cycles. PCR products were analysed by 6% 374
PAGE. 375 376
Luciferase-based interferon expression assays 377
For luciferase assays, RNP reconstitutions were performed in wild-type HEK 293T 378 cells or HEK 293T cells engineered to express luciferase from the IFN-b promoter. 379 RNP reconstitutions were performed in a 24-well format by transfecting 0.25 µg of the 380 plasmids pcDNA3-NP, pcDNA3-PB2, pcDNA3-PB1, pcDNA3-PA, a pPOLI plasmid 381 encoding full-length or truncated vRNA templates using lipofectamine2000 382 (Invitrogen). For RNP reconstitutions in wild-type HEK 293T cells, 100 ng of pIFD(-383 116)lucter and pJatLacZ were co-transfected with the polymerase expressing plasmids. 384
Twenty-four hours post transfection, cells were harvested in PBS and resuspended in 385
Reporter Lysis buffer (Promega). Luciferase activity was measured using a Luciferase 386
Assay System (Promega) and a GloMax (Promega), and normalised using the b-387 galactosidase signal measured using ortho-Nitrophenyl-β-galactoside (ONPG) and a 388
GloMax. The background was subtracted using signals obtained from cells transfected 389 with an empty pcDNA3. Luciferase levels were corrected for viral RNA levels obtained 390 with primer extensions and a 32 P-labelled NP-2 primer (Table S3 ). For total RNA 391 transfections, 100 ng of total RNA was transfected with 100 ng of pIFD(-116)lucter and 392 pJatLacZ using Lipofectamine2000. Analysis of luciferase expression was performed 393 as described above. Statistical analysis was carried out using ANOVA. To spike viral RNA for quantitative sequencing, 0.2 µl of 100 pM spike RNA (Table  472 S2) was added to 40 ng of the small RNA fraction (see above). The RNA mixture was 473 next converted into cDNA using primers Lv3aa, Lv3ga and Lc3 and Superscript III 474 (Invitrogen) at 37 ºC for 30 min. Second strand synthesis was performed using Q5 475 polymerase (NEB) and primers Lv5, Lc3a, and Lc3g at 47 ºC for 10 min, followed by 476 a further extension at 72 ºC for 3 min. The excess of barcoded primers was removed by 477 incubating the second strand reaction with 1 U of exonuclease VII (NEB) at 37 ºC for 478 1 h. The exonuclease was inactivated at 95 ºC for 10 min. Next, the DNA was amplified 479 using Q5 polymerase, primer P5 and i7 index primers (Lexogen), and subsequently 480 sequenced on a NextSeq 500 sequencer (Illumina). 481 482
Preparation of reference genome files for deep sequencing of mvRNAs 483
Prior to mapping, a reference genome file was prepared from relevant viral reference 484 sequences in Genbank (see above). For the analysis of sequencing libraries prepared 485 using universal influenza virus primers, the 5′ and 3′ viral promoter sequences of each 486 segment were modified to match the degenerate universal primer sequences used in 487 sample preparation (see Table S3 ), and the sequences of the spiked-in mvRNA 488 quantitation standards (see Table S2 ) were appended to the reference genome. For WSN, VN04, and VN04 hf viruses, deep-sequencing data of mRNA generated in A549 490 cell infections (above) was exploited to generate updated reference genome files: the 491 mpileup and consensus commands in the bcftools software package 41 were used 492 following mapping of non-host mRNA reads to the relevant viral reference genome 493 using STAR aligner 42 . 494 495 Data processing pipeline for deep sequencing of mvRNAs using universal 496 influenza virus primers 497
Raw sequencing reads were first trimmed to remove sequencing adaptor sequences and 498 reads with quality scores less than 20 using the cutadapt software package 43 and the 8-499 nt unique molecular identifier (UMI) at the start of each read were removed from the 500 sequence and appended to the read ID line of the FASTQ file using the extract 501 command from the umi_tools software package 44 . Sequencing reads were then mapped 502 end-to-end to the appropriate viral reference genome using the STAR aligner 42 , and 503 permitting sequencing reads to have long internal deletions (i.e. an mvRNA, interpreted 504 as splicing by STAR) with at least 16 nt anchored on either side of the deletion (--505 outSJfilterOverhangMin 16 16 16 16). The default settings of STAR were modified so 506 that no alignment scoring penalty was given for an internal deletion and no preference 507 was given to internal deletions that overlapped particular sequence motifs (--508 scoreGapNoncan 0 --scoreGapGCAG 0 --scoreGapATAC 0), and to ensure accurate 509 quantitation, only the top-scoring alignment was included in the outputted BAM file (-510 -outSAMmultNmax 1), which was sorted and indexed using samtools 45 . An aligned read 511 was counted as an mvRNAs if it was anchored to the viral reference genome at the 5′ 512 end in vRNA sense and contained an internal deletion (called as a splice junction by 513 STAR), and the total numbers of mvRNAs and spiked-in quantitation standards were 514 tallied using the idxstats command of samtools. mvRNA levels relative to the 515 quantitation were then reported as number of reads per million mapped (RPM) 516 quantitation standard. To validate the qPCR protocol used to prevent over-cycling of 517 sequencing libraries, the quantitation was then repeated following removal of PCR 518 duplicates, exploiting the UMI appended to each read, using the umi_tools dedup 519 command, and counting the various mvRNA species as unique using the --spliced-is-520 unique option. The identities of the individual mvRNAs were then extracted from the 521 SJ.out.tab file generated by STAR. 522
Data processing pipeline for deep sequencing of mvRNAs using adapter ligation 524
Raw sequencing reads were first trimmed using the cutadapt software package 43 to 525 remove RNA adapters, sequencing adapters, and reads with quality scores less than 20. 526
Since adapter ligation captures both host-derived and virus-derived small RNA species, 527 reads were first mapped end-to-end to the DASHR database of human small RNAs 46 528 using the STAR aligner 42 , with spliced alignments disabled (--alignIntronMax 1). Non-529 human reads were outputted using the --outReadsUnmapped Fastx option, were then 530 mapped to the appropriate viral reference genome to find mvRNAs as described above, Modulation by viral factors (e.g., NS1, PA-X, PB1-F2)
